Fortress Biotech, Inc. (FBIO)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 7M 14M 21M Q3 '24: 14.6M Q4 '24: 15.1M Q1 '25: 13.1M Q2 '25: 16.4M Q3 '25: 17.6M Q4 '25: 16.1M Q1 '26: 16M Q2 '26: 18.7M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Gross Profit Quarterly

0 700K 1.4M 2.1M Q2 '15: 0 Q3 '15: 25K Q2 '16: 1.9M Q3 '16: 934K Q2 '15 Q3 '15 Q2 '16 Q3 '16

Operating Income Quarterly

-45M -30M -15M 0 15M 30M 45M Q3 '24: -22.1M Q4 '24: -23.8M Q1 '25: -22.3M Q2 '25: -36.5M Q3 '25: -6.8M Q4 '25: -4.8M Q1 '26: -7.7M Q2 '26: -10M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Net Income Quarterly

-40M 0 40M 80M 120M Q3 '24: -12.9M Q4 '24: -6.8M Q1 '25: -10.6M Q2 '25: 15.5M Q3 '25: 5.8M Q4 '25: -3.9M Q1 '26: 110.4M Q2 '26: -468K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Cost of Revenue Quarterly

0 2.5M 5M 7.5M Q3 '24: 4.5M Q4 '24: 4.7M Q1 '25: 4.8M Q2 '25: 4.9M Q3 '25: 5.8M Q4 '25: 5.4M Q1 '26: 6.2M Q2 '26: 6.1M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating Cash Flow Quarterly

-70M 0 70M 140M 210M Q3 '24: -20.1M Q4 '24: -12.9M Q1 '25: -19.6M Q2 '25: -27.6M Q3 '25: -6.1M Q4 '25: -12.5M Q1 '26: 203.9M Q2 '26: -59.3M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Free Cash Flow Quarterly

-60M -40M -20M 0 20M 40M 60M Q3 '22: -44.3M Q4 '22: -47.9M Q1 '23: -43.2M Q2 '23: -33.3M Q3 '23: -16.8M Q4 '23: -35M Q3 '24: -20.1M Q4 '24: -12.9M Q3 '22 Q4 '22 Q1 '23 Q2 '23 Q3 '23 Q4 '23 Q3 '24 Q4 '24

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 15M 30M 45M Q1 '24: 17.2M Q2 '24: 18.3M Q3 '24: 19.7M Q1 '25: 26.5M Q2 '25: 29.8M Q3 '25: 33.1M Q1 '26: 38.4M Q2 '26: 31.8M Q1 '24 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-4.50 -3.00 -1.50 0.00 1.50 3.00 4.50 Q2 '24: -3.24 Q3 '24: -3.06 Q4 '24: -2.79 Q1 '25: -2.23 Q2 '25: -1.05 Q3 '25: -0.18 Q4 '25: -0.07 Q1 '26: 3.23 Q2 '24 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.